HORIZON EUROPE – HORIZON-JU-GH-EDCTP3-2025-01-two-stage – 2025

Objectives 

• To increase international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve the reduction of disease burden in SSA through the development of vaccines
• To increase international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve rapid advances in the development of new or improved anti-malarial drugs or drug combinations
• To progress the development of prophylactic vaccines against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa

TOPICS: 

Open 

• HORIZON-JU-GH-EDCTP3-2025-01-TB-01-two-stage: Global collaboration action for the development of vaccines for reducing the disease burden of Tuberculosis in sub-Saharian Africa
• HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02-two-stage: Global collaboration action for research on existing Malaria therapeutics and clinical development of new antimalarial candidates
• HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage: Accelerating the development of prophylactic vaccines against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa

Additional information 

To find your national contact point: Click here

Useful 

• Guidelines: Click here
• Other call documents: Click here 
• Executive agency website: Click here 
• More information: Click here

• Total budget of the call: Detailed budget below
• Budget per topic:
  • HORIZON-JU-GH-EDCTP3-2025-01-TB-01-two-stage: 45.900.000 euros
  • HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02-two-stage: 30.900.000 euros
  • HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage: 45.900.000 euros